Commentary:Clinical trials methods and the practice of medicine

Jeffrey L. Probstfield, Michael L. Russell, Abraham Silvers, Dwight L. Goodwin, William Insull

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

An important potential byproduct from clinical trials is validated clinicalmethods applicable to clinical practice. The potential for improved patient care is separate from the scientific and intellectual answers gained in such trials. The current mechanisms for the transfer of methodological information from clinical trials are inefficient and have identifiable barriers. Methods validated in clinical trials must be recognized and accentuated as a valuable resource. A central repository of clinical trials' methods and a retrieval system dedicated to this unique body of scientific literature is warranted. Reports of methodological advances from clinical trials should be published in the literature read by clinical practitioners. The effective transfer of methods information from clinical trials to the office of the clinical practitioner is possible but requires increased efforts on the part of clinical trials scientists.

Original languageEnglish (US)
Pages (from-to)321-327
Number of pages7
JournalControlled Clinical Trials
Volume5
Issue number4 SUPPL. 1
DOIs
StatePublished - Dec 1984

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Commentary:Clinical trials methods and the practice of medicine'. Together they form a unique fingerprint.

Cite this